Christine Dolan - Jan 16, 2024 Form 4 Insider Report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Role
Executive Vice President & General Manager, Cygnus Technologies
Signature
/s/ Kurt Oreshack, by power of attorney for Christine Dolan
Stock symbol
MRVI
Transactions as of
Jan 16, 2024
Transactions value $
$0
Form type
4
Date filed
1/18/2024, 06:21 PM
Previous filing
Nov 16, 2023
Next filing
Feb 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRVI Class A Common Stock Award +190K +250.38% 265K Jan 16, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in one-half (1/2) increments on each of January 15, 2025, and January 15, 2026, subject to the Reporting Person's continued employment with the Issuer.

Remarks:

Executive Vice President & General Manager, Cygnus Technologies